Abstract
AbstractThis open study investigated the clinical effects of 10-week selegiline administration in six patients in vegetative state and in four patients in a minimally conscious state, at least 6 months after onset. Clinical outcome was assessed by Coma Recovery Scale-Revised once a week during selegiline administration and 1 month later. Three patients stopped treatment because of possible side effects. After treatment and at 1 month of follow-up, four patients showed improvements in clinical diagnosis, and three patients showed an increase in arousal level only. Selegiline might represent a relatively safe option to enhance arousal and promote recovery in brain-injured patients with disorders of consciousness.
Publisher
Cambridge University Press (CUP)
Subject
Neurology (clinical),Neurology,General Medicine
Reference12 articles.
1. Pharmacological Treatments
2. Monoamine oxidase B inhibitors for early Parkinson’s disease;Macleod;Cochrane Database Syst Rev,2005
3. An explorative study regarding the effect of l-deprenyl on cognitive and functional recovery in patients after stroke
4. Medline Plus (2017) https://medlineplus.gov/druginfo/meds/a697046.html.
5. An Italian multicentre validation study of the coma recovery scale-revised;Estraneo;Eur J Phys Rehabil Med,2015
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献